University Of Wisconsin Madison is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| University of Wisconsin-Madison | |
|---|---|
| Location | Madison, Wisconsin, USA |
| Type | Public Research University |
| Founded | 1848 |
| Enrollment | ~49,000 students |
| Website | https://wisc.edu |
The University of Wisconsin-Madison (UW-Madison) is a public research university and one of the founding members of the Association of American Universities. The university has a world-renowned reputation in neuroscience, aging research, and biomarker discovery, making it a major contributor to neurodegenerative disease research.
UW-Madison has been at the forefront of Alzheimer's disease and aging research for decades. The Wisconsin Alzheimer's Disease Research Center (WADRC) and the Wisconsin Registry for Alzheimer's Prevention (WRAP) are internationally recognized programs that have advanced understanding of preclinical Alzheimer's disease and risk factors.
The WADRC (https://medicine.wisc.edu/research/alzheimers) is an NIH-funded Alzheimer's Disease Research Center featuring:
The Center for Healthspan Research (https://snphy.wisc.edu) focuses on:
The Neurology Department (https://neurology.wisc.edu) provides:
The Interdisciplinary Neuroscience Program (https://neuroscience.wisc.edu) trains the next generation of neuroscientists with strong emphasis on neurodegeneration research.
| Area | Focus | Notable Contributions |
|---|---|---|
| Alzheimer's Prevention | WRAP cohort, risk factors, biomarkers | Largest family history AD cohort |
| Biomarkers | CSF, blood, imaging biomarkers | ADCS biomarker standardization |
| Aging Biology | Senolytics, healthspan, geroscience | Rapamycin clinical trials |
| Neuroimaging | PET, MRI, tau imaging | Tau PET validation |
The study of University Of Wisconsin Madison has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Wisconsin Alzheimer's Disease Research Center. (2024). Annual Report. https://medicine.wisc.edu
[2] Johnson, S.C., et al. (2024). Wisconsin Registry for Alzheimer's Prevention: 20 years of insights into preclinical Alzheimer's disease. Alzheimer's & Dementia.
[3] UW-Madison School of Medicine and Public Health. (2024). Neurology Research Programs.
[4] National Institute on Aging. (2024). Alzheimer's Disease Research Centers Program.
[5] Waisman Center. (2024). Neurodegeneration Research. https://waisman.wisc.edu